Cystamine-Boronic Acid Electrode for Glycoprotein Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing electrodes for measuring glycated hemoglobin have limitations in binding sufficient boronic acid, leading to insufficient reaction density and accuracy in measuring glycoproteins.

Innovation Solution

Conjugating cystamine with boronic acid, specifically 3-formylphenyl boronic acid, to the electrode surface using a disulfide group, allowing for a higher density of boronic acid binding, which enhances the measurement of glycoproteins like glycated hemoglobin.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If 4-formyl-phenylboronic acid is bound to the electrode surface by dendrimer, then the electrode can measure glycated hemoglobin, but the reaction of glycated hemoglobin is insufficient and the density of boronic acid bound to the electrode surface is low

Engineering Contradiction:
Improvedensity of boronic acid bound to electrode surfaceVSAvoidaccuracy of glycated hemoglobin measurement
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent introduces a self-assembled monolayer (SAM) consisting of cystamine and boronic acid as an intermediary layer between the electrode surface and glycated hemoglobin. This SAM structure provides a higher density of boronic acid groups compared to dendrimer-based approaches, enabling more effective binding to glycated hemoglobin while maintaining measurement accuracy. The cystamine-boronic acid conjugate serves as the mediating structure that resolves the contradiction between binding density and measurement precision.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If more boronic acid is bound to the electrode surface, then the measurement accuracy of glycoprotein increases, but the complexity of electrode preparation increases

Engineering Contradiction:
Improveaccuracy of glycoprotein measurementVSAvoidcomplexity of electrode preparation process
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-conjugating cystamine with boronic acid to form a self-assembled monolayer before electrode assembly. This pre-prepared SAM structure allows for high-density boronic acid binding to the electrode surface through a simplified one-step immobilization process, rather than requiring complex multi-step procedures. The pre-formed cystamine-boronic acid conjugate ready for electrode attachment, thereby achieving high measurement accuracy while reducing preparation complexity.

Inventive Principle:
Principle #10Preliminary action

3Ease of manufacture

If dendrimer is used to bind boronic acid to the electrode, then the electrode structure is formed, but the reaction efficiency with glycated hemoglobin is insufficient

Engineering Contradiction:
Improveease of electrode fabricationVSAvoidreaction efficiency with glycated hemoglobin
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent applies parameter changes by transitioning from dendrimer-based boronic acid attachment to a self-assembled monolayer of cystamine-boronic acid. This structural parameter change results in higher boronic acid density and improved accessibility to glycated hemoglobin, thereby enhancing reaction efficiency. The SAM structure provides optimal spacing and orientation of boronic acid groups, improving the kinetics and extent of reaction with glycated hemoglobin while maintaining ease of electrode fabrication through straightforward immobilization procedures.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach increases the accuracy of glycoprotein measurement by increasing the amount of boronic acid bound to the electrode surface, improving the sensitivity and reliability of electrochemical signals, particularly for glycated hemoglobin detection.

Implementation Method 1

cystamine is bound to the surface of the electrode by the disulfide group of the cystamine

Methodology Applied
Scientific EffectChemisorption: Chemisorption

Implementation Method 2

boronic acid has the property of binding specifically to sugars and glycoprotein by interaction with the cis-diol

Methodology Applied
Scientific EffectSpecific binding interaction: Adsorption

Data Source

PatentEP2546653B1Electrode for Measuring Glycoprotein and Preparation Method Thereof
Publication Date: 2015.04.15 LG ELECTRONICS INC
  • EP2546653B1 patent drawingFigure 1
  • EP2546653B1 patent drawingFigure 2~3
  • EP2546653B1 patent drawingFigure 4~5

AI summary

Disclosed herein are an electrode for measuring glycoprotein and a preparation method thereof. In the electrode, cystamine is bound to the electrode surface, and boronic acid is conjugated to the cystamine. Thus, an increased amount of boronic acid can be bound to the electrode surface, so that the amount of glycoprotein can be more accurately measured using the electrode.